1310950-08-3

Upstream product

• 1227564-32-0 C₇H₈ClNO₂ 
• 128072-93-5 ethyl 5-chloropyridine-2-carboxylate 
• 1310950-07-2 3-chloro-6-{(E)-2-cyclopentyl-1-[4-(methylsulfanyl)phenyl]ethenyl}-2-methoxypyridine 
• 1310950-06-1 3-chloro-6-{(E)-2-cyclopentyl-1-[4-(methylsulfanyl)phenyl]ethenyl}pyridin-2(1H)-one 
• 1214388-09-6 ethyl 5-chloro-6-methoxypyridine-2-carboxylate 
• 1214347-24-6 ethyl 5-chloro-6-hydroxypyridine-2-carboxylate 
• 1310949-27-9 5-chloro-2-(ethoxycarbonyl)pyridine 1-oxide 
• 1310947-46-6 (5-chloro-6-methoxypyridin-2-yl)[4-(methylsulfanyl)phenyl]methanol 
• 1211527-87-5 5-chloro-6-methoxypyridin-2-carbaldehyde 
• 1310947-45-5 (5-chloro-6-methoxypyridin-2-yl)[4-(methylsulfanyl)phenyl]methanone 
• 54221-96-4 6-methoxypyridine-2-carbaldehyde 
• 86873-60-1 5-chloropicolinic acid 

Relevant academic research and scientific papers

2-PYRIDONE COMPOUNDS

A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.